Antitumor therapeutic effects of a genetically engineered Salmonella typhimurium harboring TNF-alpha in mice
- Authors
- Yoon, Won Suck; Chae, Yang Seok; Hong, Juyeon; Park, Yong Keun
- Issue Date
- 3월-2011
- Publisher
- SPRINGER
- Keywords
- Antitumor effects; Tumor treatments; TNF-alpha; Salmonella typhimurium
- Citation
- APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, v.89, no.6, pp.1807 - 1819
- Indexed
- SCIE
SCOPUS
- Journal Title
- APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Volume
- 89
- Number
- 6
- Start Page
- 1807
- End Page
- 1819
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/112921
- DOI
- 10.1007/s00253-010-3006-4
- ISSN
- 0175-7598
- Abstract
- Although the use of TNF-alpha in the treatment of cancer is restricted due to its non-specific cytotoxicity and narrow range of applications to different cancers in clinical trials, we investigated a safe anti-cancer drug by the use of engineered bacterial capsule harboring TNF-alpha. The engineered bacterial capsule was designed to target cancer cells, promote a tumor-suppressive environment, and increase the efficacy of existing cancer treatments, including chemotherapy, radiotherapy, and cell therapy. The engineered bacterial capsule was constructed with Salmonella capsulizing TNF-alpha protein, which was produced and capsulized by Salmonella to reduce side effects of the protein. This bacterial capsule induced a tumor-suppressive environment through the activation of natural killer cells. Engineered bacterial capsule invaded tumor cells, released TNF-alpha, and induced apoptosis of tumor cells without apparent side effects. In a murine melanoma model, the bacterial capsule of TNF-alpha significantly inhibited tumor growth by 80-100% and prolonged the survival of the mice. When tested in combination with chemotherapy (cisplatin), antibiotics, and vaccine, recombinant microbial treatment increased the anti-tumor effects of existing therapies. The anti-tumor effects of the bacterial capsule of TNF-alpha were also observed in cervical cancer, melanoma, breast cancer, colon cancer, and renal carcinoma. These results suggest that the bacterial capsule of TNF-alpha is a promising strategy for TNF-alpha treatment.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
- College of Life Sciences and Biotechnology > Division of Life Sciences > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholar.korea.ac.kr/handle/2021.sw.korea/112921)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.